The aim of this study was to investigate whether nebivolol has added effects on left ventricular (LV) dysfunction and remodeling early after myocardial infarction (MI) beyond its β₁-receptor-blocking properties
Nebivolol is a new β1-antagonist that acutely reduces arterial blood pressure without depressing car...
Endothelial dysfunction is major pathophysiologic mechanism in cardiac syndrome X (CSX), which cause...
Areas covered in the review: We describe the role of the sympathetic nervous system, beta-blockers a...
ObjectivesThe aim of this study was to investigate whether nebivolol has added effects on left ventr...
Objective: Ventricular remodeling (VR) which develops after myocardial infarction (MI) plays an impo...
<div><p>Nebivolol, third-generation β-blocker, may activate β3-adrenergic receptor (AR), which has b...
Although its clinical use in Europe dates almost 10 years, nebivolol is a β-blocker that has been on...
Endothelial dysfunction is a systemic pathological state of the endothelium characterized by a reduc...
The importance of chronic stimulation of β-adrenoceptors in the development of cardiac dysfunction i...
<p>(a) Representative Masson's trichrome staining revealed left ventricular fibrosis 4 weeks after M...
Abstractβ-adrenergic blocking agents, a pharmacologically diverse class of cardiovascular medication...
International audienceEndothelial cell (EC) dysfunction plays a central role in the pathogenesis of ...
BackgroundEndothelial cell (EC) dysfunction plays a central role in the pathogenesis of pulmonary ar...
AbstractBackgroundEndothelial cell (EC) dysfunction plays a central role in the pathogenesis of pulm...
OBJECTIVE: After MI pathological LV remodeling is one of the major causes of death. We previously sh...
Nebivolol is a new β1-antagonist that acutely reduces arterial blood pressure without depressing car...
Endothelial dysfunction is major pathophysiologic mechanism in cardiac syndrome X (CSX), which cause...
Areas covered in the review: We describe the role of the sympathetic nervous system, beta-blockers a...
ObjectivesThe aim of this study was to investigate whether nebivolol has added effects on left ventr...
Objective: Ventricular remodeling (VR) which develops after myocardial infarction (MI) plays an impo...
<div><p>Nebivolol, third-generation β-blocker, may activate β3-adrenergic receptor (AR), which has b...
Although its clinical use in Europe dates almost 10 years, nebivolol is a β-blocker that has been on...
Endothelial dysfunction is a systemic pathological state of the endothelium characterized by a reduc...
The importance of chronic stimulation of β-adrenoceptors in the development of cardiac dysfunction i...
<p>(a) Representative Masson's trichrome staining revealed left ventricular fibrosis 4 weeks after M...
Abstractβ-adrenergic blocking agents, a pharmacologically diverse class of cardiovascular medication...
International audienceEndothelial cell (EC) dysfunction plays a central role in the pathogenesis of ...
BackgroundEndothelial cell (EC) dysfunction plays a central role in the pathogenesis of pulmonary ar...
AbstractBackgroundEndothelial cell (EC) dysfunction plays a central role in the pathogenesis of pulm...
OBJECTIVE: After MI pathological LV remodeling is one of the major causes of death. We previously sh...
Nebivolol is a new β1-antagonist that acutely reduces arterial blood pressure without depressing car...
Endothelial dysfunction is major pathophysiologic mechanism in cardiac syndrome X (CSX), which cause...
Areas covered in the review: We describe the role of the sympathetic nervous system, beta-blockers a...